Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA, EMA move against Avastin for breast cancer
FDA, EMA move against Avastin for breast cancer
FDA, EMA move against Avastin for breast cancer
Submitted by
admin
on December 16, 2010 - 12:43pm
Source:
Fierce Pharma
News Tags:
FDA
EMA
Avastin
breast cancer
Roche
Headline:
FDA, EMA move against Avastin for breast cancer
Do Not Allow Advertisers to Use My Personal information
